The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment Option Overview

Added le Coutre et al. as reference 9.

Chronic-Phase Chronic Myelogenous Leukemia

Added text to update long-term follow-up statistics for response, survival, and safety with imatinib mesylate therapy after failure of interferon-alpha (cited Hochhaus et al. as reference 3).

Cited le Coutre et al. as reference 15; added Shah et al. as reference 19.

Added Deenik et al. as reference 21.

Relapsing Chronic Myelogenous Leukemia

Cited le Coutre et al. as reference 3.

Back to Top

< Previous Section  |  Next Section >